Roche Pharmaceuticals CEO Teresa Graham talks innovation, and changing the standard of care
Speaking at the JPMorgan Healthcare Conference, Roche Pharmaceuticals (RHHBY) CEO Teresa Graham discusses the company's innovation focus and outlook with Yahoo Finance's Anjalee Khemlani. Graham says Roche has "defined itself as a company that follows innovation" across health care sectors. Currently, they see huge potential in the obesity drug space as analysts forecast the weight loss market reaching $100 billion within years. However, Roche hopes to expand cretinism beyond obesity into neurological disease applications. On dealmaking, Graham notes Roche pursues "groundbreaking science" thatβ¦